“Dr. Tarasow has a proven track that spans early phase research, product development, and commercial laboratory operations. This experience makes him uniquely suited to succeed at HealthTell”, said Bill Colston, CEO.
San Ramon, CA (PRWEB) June 25, 2013
Most recently Vice President of Research and Development at Tethys Bioscience, Dr. Tarasow brings a keen understanding of what it takes to develop and operate a transformational new medical diagnostic service.
“Dr. Tarasow has a proven track that spans early phase research, product development, and commercial laboratory operations. This experience makes him uniquely suited to succeed at HealthTell”, said Bill Colston, CEO of HealthTell. “Ted is a key addition to the management team and we are fortunate to be able to take advantage of his deep expertise and experience.”
Prior to joining Tethys Bioscience, Dr. Tarasow held senior leadership positions in multiple organizations, including Lawrence Livermore National Laboratory, Invenux and NeXstar Pharmaceuticals. A common theme across these companies was Dr. Tarasow’s ability to build and effectively lead multi-disciplinary teams responsible for the research, development and technical commercialization of complex science and technologies.
Dr. Tarasow received his B.S. degree in Chemistry from California Polytechnic State University, San Luis Obispo and his Ph.D. in Organic Chemistry from the Scripps Research Institute.
HealthTell is an early stage start-up company that is developing powerful new tools to help individuals monitor their health status. This technology has already been demonstrated to work for over 30 diverse illnesses, ranging from cancer to infectious disease. The test is simple and inexpensive, and can be performed with only a single drop of blood.
More information about HealthTell is available at http://www.healthtell.com.